PLI Scheme Disburses ₹87.7 Crore for Bulk Drug Production
Under the same incentive framework, the bulk‑drug segment has received 87.70 crore rupees out of a total allocation of 6,940 crore. The disbursement covers projects that manufacture generic medicines at large scale and is slated to continue until the end of March 2026.